Immunomodulation for primary prevention of urinary tract infections in patients with spinal cord injury during primary rehabilitation: protocol for a randomized placebo-controlled pilot trial (UROVAXOM-pilot)

Immunomodulation for primary prevention of urinary tract infections in patients with spinal cord injury during primary rehabilitation: protocol for a randomized placebo-controlled pilot trial (UROVAXOM-pilot)

Abstract Background Urinary tract infections (UTIs) are common in individuals with neurogenic lower urinary tract dysfunction (NLUTD) following spinal cord injury (SCI). They are not only a great burden for affected individuals, but also cause considerable health costs. Furthermore, recurrent antibi...

Full description

Bibliographic Details
Main Authors: Jörg Krebs, Jivko Stoyanov, Jens Wöllner, Ezra Valido, Jürgen Pannek
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Trials
Subjects:
Spinal cord injury
Neurogenic lower urinary tract dysfunction
Urinary tract infection
Escherichia coli
Uro-Vaxom®
Immunotherapy
Online Access:https://doi.org/10.1186/s13063-021-05630-w

Internet

https://doi.org/10.1186/s13063-021-05630-w

Similar Items